SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
394 Merz awarded prize for memantine development. I found this on the Merz site. ThDr. John M. de Castro-12/1/1998
393 Hi John, I have found that technical journals are the best place to get a balaBRAVEHEART-11/19/1998
392 NTII is the headline story in the Nov. 18 BioWorld Today entitled "NeurobiDr. John M. de Castro-11/19/1998
391 Jeffrey, Good question regarding the Orphan Drug status. I don't know the aDr. John M. de Castro-11/19/1998
390 Hi Gang, Why hasn't NTII sought orphan drug status for Memantine for Aid&#BRAVEHEART-11/19/1998
389 Nah, the mode of action of memantine to protect against AIDS Dementia is not coDr. John M. de Castro-11/18/1998
388 At the meeting, Lisa Carr explained some of the science behind Memantine and AIJMarcus-11/17/1998
387 I just got confirmation from NTII that the Phase II memantine trial for AIDS DeDr. John M. de Castro-11/17/1998
386 Reviewing my notes from the stockholders meeting, I can't find any referencJMarcus-11/16/1998
385 Will NTII be using the AIDS Dementia Phase II trial as pivotal? I've speculDr. John M. de Castro-11/16/1998
384 I checked my notes and still don't recall any hints about who the 4 suitorsJMarcus-11/13/1998
383 "Freiman said that he is in advanced stages of negotiating a marketing parDr. John M. de Castro-11/13/1998
382 You also asked about the new PR firm. Representatives from the firm were preseJMarcus-11/13/1998
381 "I was wondering if by year end 1999 you mean fiscal year end June 30th 19JMarcus-11/13/1998
380 J. Marcus - Thank you for the excellent report. I have to admit being disappoinDr. John M. de Castro-11/13/1998
379 Hi John, Unfortunately my inquiry was with respect to that very post ( 349 ) aBRAVEHEART-11/13/1998
378 Hi J Marcus, I too appreciate your highly detailed and informative post. I waBRAVEHEART-11/13/1998
377 Thank you very much for posting your summary of the shareholders meeting. YourVikingWarrior-11/12/1998
376 I attended the stockholders meeting today. Here are some highlights. Paul FreJMarcus-11/12/1998
375 Hi John, I appreciate your insight on this matter. The quote is suggestive isBRAVEHEART-11/12/1998
374 Annual Meeting Highlights biz.yahoo.com I hope that someone who attended the Dr. John M. de Castro-11/12/1998
373 The Xerecept trial is not pivotal. If the Phase II is successful, then NTII wilDr. John M. de Castro-11/9/1998
372 Jeffrey, Could you repost the story. The link that you posted leads to an eDr. John M. de Castro-11/9/1998
371 I won't be at the annual meeting. Unfortunately, until NTI stock hits $10, Dr. John M. de Castro-11/9/1998
370 Hi John, I was just going over prior posts. Could you shed any more light on BRAVEHEART-11/7/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News